|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 353.95 CHF | -1.35% |
|
-2.39% | +8.14% |
| 03-03 | Roche to Enter Weight-loss Drugs Market in 2029, CEO Says | MT |
| 03-03 | Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports | RE |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 19.12x | 6.68x | 1.13x | 4.71x | 11.64x | 13.24x | 2.8% | 368B | ||
| 29.49x | 18.18x | 0.61x | 11.11x | 22.31x | 23.67x | 0.66% | 897B | ||
| 24.97x | 6.76x | -2.28x | 6.05x | 16.49x | 18.21x | 2.16% | 591B | ||
| 25.65x | 74.06x | 0.09x | 6.99x | 14.03x | 14.39x | 2.93% | 418B | ||
| 25.48x | 5.76x | 1.21x | 5.28x | 14.64x | 15.71x | 1.65% | 313B | ||
| 22.17x | 6.61x | 9.36x | 5.97x | 14.72x | 15.8x | 2.69% | 312B | ||
| 28.12x | 5.26x | -0.68x | 4.91x | 15.36x | 18.13x | 2.81% | 297B | ||
| 25.52x | 17.14x | 5.72x | 6.45x | 11.47x | 14.64x | 2.65% | 204B | ||
| 20.55x | 6.96x | 3.21x | 6.25x | 11.3x | 13.31x | 2.2% | 184B | ||
| 11.6x | 4.97x | -1.43x | 4.21x | 8.71x | 10.18x | 4.39% | 170B | ||
| 12.45x | 1.66x | 0.22x | 3.16x | 7.56x | 8.95x | 6.6% | 151B | ||
| 12.46x | 5.45x | 0.28x | 3.25x | 8.76x | 9.41x | 4.04% | 127B | ||
| 27.24x | 5.36x | 1.88x | 8.21x | 18.45x | 19.06x | -.--% | 121B | ||
| 15.23x | 5.9x | 0.13x | 3.04x | 8.8x | 10.25x | 3.06% | 113B | ||
| 12.14x | 1.23x | 6.03x | 2.28x | 7.54x | 8.14x | 5.33% | 111B | ||
| 37.51x | 8.11x | 3.58x | 12.16x | 23.89x | 25.47x | 2.6% | 102B | ||
| 50.57x | 1.27x | 0.81x | 2.82x | 10.47x | 29.74x | 3.57% | 56.42B | ||
| 40.8x | 5.76x | 1.37x | 9.52x | 32.27x | 33.49x | 0.49% | 50.84B | ||
| 21.96x | 2.09x | 1.8x | 3.79x | 15x | 16.79x | 1.83% | 46.04B | ||
| Average | 24.37x | 9.96x | 1.74x | 5.80x | 14.39x | 16.77x | 2.76% | 243.86B | |
| Weighted average by Cap. | 24.34x | 14.77x | 1.25x | 6.67x | 15.37x | 17.04x | 2.38% |
- Stock Market
- Equities
- ROG Stock
- Sector Roche Holding AG
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















